电邮这篇文章 Treatment of Primary Stages of Coxarthrosis by Intraarticular Injections of Chondroprotectors under Roentgenologic Control
- 作者: Cherkes-Zade DD, Miti A
- 期: 卷 17, 编号 1 (2010)
- 页面: 88-89
- 栏目: Articles
- URL: https://journal-vniispk.ru/0869-8678/article/view/47981
- DOI: https://doi.org/10.17816/vto201017188-89
- ID: 47981
如何引用文章
全文:
详细
Technique of medicinal preparation (chondroprotectors Synvisc) injection into hip joint cavity under roentgenologic control is described. Technique has been applied in 12 patients (14 procedures) with primary stages of coxarthrosis. Positive effect has been achieved in all cases. In comparison with the performance of intraarticular injections using echography the presented technique is more accurate and simple for the procedure documenting. Duration of manipulation makes up 5-7 minutes.
参考
- Aural X. Injections in the treatment of osteoarthritis //Best Pract. Res. Clin. Rheumatol. - 2001. - Vol. 15. - P. 609-626.
- Caglar-Yagci H., Unsal S., Yagci I. et al. Safety and efficacy of ultrasound-guided intraarticular hylan G-F 20 injection in osteoarthritis of the hip: a pilot study //Rheumatol. Int. - 2005. - Vol. 25. - P. 341-344.
- Innocenti M. et al. Viscosupplementation in hemophilic artropathy //GIOT. - 2006. - Vol. 32. - P. 215-221.
- Migliore A. et al. Open pilot study of ultrasound-guided intra-articular injections of hylan G-F 20 (Synvisc) in the treatment of symptomatic hip osteoarthritis //Clin. Rheumatol. - 2004. - Vol. 24. - P. 285-289.
- Migliore A. et al. Profilo di sicurezza di 185 iniezioni intraarticolari sotto guida ecografica nelle coxopatie //Reumatismo. - 2004. - Vol. 56, N 2. - P. 104-109.
- Vad V., Sakalkate D., Sculco T., Wickiewicz T. Role of Hylan G-F 20 in treatment of osteoarthritis of the hip joint //Arch. Pys. Med. Rehabil. - 2003. - Vol. 84. - P. 1224-1226.
- Watterson J., Esdaile M. Perspectives on modern orthopaedics. Viscosupplementation: Therapeutic mechanisms and clinical potentiale in osteoarthritis of the knee //AAOS. - 2000. - Vol. 8. - P. 5.
补充文件
